+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Acute non b hepatitis in the israel defense forces comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis

Acute non b hepatitis in the israel defense forces comparison of some epidemiologic features before and after the usage of preexposure immune serum globulin prophylaxis

Hepatology 7(6): 1330-1332

Large-scale epidemics of non-B (HBsAg-negative) hepatitis have occurred in the Israel Defense Forces prior to post- and preexposure immune serum globulin administration. Presently, hepatitis morbidity rates have stabilized around 1 to 2 per 1,000. Several years after vaccine initiation, a comparison of epidemiological features was made in order to redefine risk groups. Seasonal morbidity, sex, ethnic origin and educational status (as a representative of socioeconomic level) were not different after the preexposure immunization compared to the preimmunization era. Therefore, a more selective immunization is proposed.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 004671421

Download citation: RISBibTeXText

PMID: 3119454

Related references

Pre exposure prophylaxis of viral hepatitis with immune serum globulin in a endemic area a trial in field units of the israel defense forces. Scandinavian Journal of Infectious Diseases 15(1): 3-6, 1983

Pre-exposure Prophylaxis of Viral Hepatitis with Immune Serum Globulin in an Endemic Area: A Trial in Field Units of the Israel Defence Forces. Scandinavian Journal of Infectious Diseases 15(1): 3-6, 1983

Apparent effect of immune serum globulin prophylaxis in the military on viral hepatitis incidence in the civilian population in Israel. Journal of Epidemiology and Community Health 43(2): 187-190, 1989

Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis. American Journal of Epidemiology 87(3): 539-550, 1968

Prophylaxis of acute viral hepatitis by immune serum globulin, hepatitis B vaccine, and health education: a sixteen year study of Japan overseas cooperation volunteers. American Journal of Tropical Medicine and Hygiene 56(1): 76-79, 1997

Combined hepatitis b immune globulin and vaccine for postexposure prophylaxis of accidental hepatitis b virus infection in hemodialysis staff members comparison with immune globulin without vaccine in historical controls. Hepatology 10(3): 324-327, 1989

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis. Vaccine 11(Suppl. 1): S9-14, 1993

Immune serum globulin and hepatitis b immune globulin for spouses and sexual partners exposed to acute type b hepatitis. Gastroenterology 79(5 Part 2): 1044, 1980

Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis. Infection 6(6): 257-258, 1978

Immune serum globulin in the prophylaxis of paralytic poliomyelitis measles infectious hepatitis hypogammaglobulinemia. The distribution and use of gamma globulin. A statement issued April 20, 1953, by the Division of Medical Sciences of the National Research Council. Plan for the allocation of gamma globulin. Issued April 15, 1953, by the Office of Defense Mobilization in the Executive Office of the President. Progress in research on poliomyelitis, by HARRY M. WEAVER. Publ Health Repts 68(7): 659-677, 1953

Use of high-titer immune serum globulin for hepatitis A prophylaxis. New England Journal of Medicine 296(25): 1478-1479, 1977

Hepatitis B prevention strategies: a benefit-cost analysis of immune serum globulin, hepatitis B immune globulin, and hepatitis B vaccine in the military. American Journal of Preventive Medicine 2(6): 359-366, 1986

Mutational analysis of hepatitis B virus from the sequential serum of the liver transplant recipient who were rapidly reinfected despite hepatitis B immune globulin prophylaxis and lamivudine therapy. Hepatology 36(4 Part 2): 617A, 2002

Immune serum globulin mass prophylaxis of hepatitis due to virus A in epidemic surroundings. American Journal of Diseases of Children 123(4): 434-435, 1972

Clinical epidemiological and prognostic aspects of hepatitis a and immune serum globulin prophylaxis. Nihon University Journal of Medicine 26(4): 267-290, 1984